Author:
Pearson Max,Haslam Carl,Fosberry Andrew,Jones Emma J.,Reglinski Mark,Reeves Lucy,Edwards Robert J.,Lawrenson Richard Ashley,Brown Jonathan C.,Mossakowska Danuta,Pease James Edward,Sriskandan Shiranee
Abstract
AbstractThe Streptococcus pyogenes cell envelope protease (SpyCEP) is vital to streptococcal pathogenesis and disease progression. Despite its strong association with invasive disease, little is known about enzymatic function beyond the ELR+ CXC chemokine substrate range. As a serine protease, SpyCEP has a catalytic triad consisting of aspartate (D151), histidine (H279), and serine (S617) residues which are all thought to be mandatory for full activity. We utilised a range of SpyCEP constructs to investigate the protein domains and catalytic residues necessary for enzyme function. We designed a high-throughput mass spectrometry assay to measure CXCL8 cleavage and applied this for the first time to study the enzyme kinetics of SpyCEP. Results revealed a remarkably low Michaelis-Menton constant (KM) of 82 nM and a turnover of 1.65 molecules per second. We found that an N-terminally-truncated SpyCEP C-terminal construct containing just the catalytic dyad of H279 and S617 was capable of cleaving CXCL8 with a similar KM of 55 nM, albeit with a reduced substrate turnover of 2.7 molecules per hour, representing a 2200-fold reduction in activity. We conclude that the SpyCEP C-terminus plays a key role in high affinity substrate recognition and binding, but that the N-terminus is required for full catalytic activity.
Funder
Biotechnology and Biological Sciences Research Council
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Carapetis, J. R. et al. The global burden of group A Streptococcal diseases. Lancet Infect. Dis. 5(11), 685–694 (2005).
2. Craik, N., et al. Global disease burden of Streptococcus pyogenes, in Streptococcus Pyogenes: Basic Biology to Clinical Manifestations, (eds Ferretti, J.J., Stevens, D.L., & Fischetti, V.A.) University of Oklahoma Health Sciences Center© The University of Oklahoma Health Sciences Center.: Oklahoma City (OK) (2022).
3. Ralph, A. P. & Carapetis, J. R. Group a streptococcal diseases and their global burden. Curr. Top. Microbiol. Immunol. 368, 1–27 (2013).
4. Edwards, R. J. et al. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J. Infect. Dis. 192(5), 783–790 (2005).
5. Kurupati, P. et al. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol. Microbiol. 76(6), 1387–1397 (2010).